Combined pharmacotherapy and psychotherapy in the treatment of mild to moderate major depression?
Publikation: Beiträge in Zeitschriften › Zeitschriftenaufsätze › Forschung › begutachtet
Standard
in: JAMA - Journal of the American Medical Association, Jahrgang 71, Nr. 7, 07.2014, S. 747-748.
Publikation: Beiträge in Zeitschriften › Zeitschriftenaufsätze › Forschung › begutachtet
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Combined pharmacotherapy and psychotherapy in the treatment of mild to moderate major depression?
AU - Cuijpers, Pim
PY - 2014/7
Y1 - 2014/7
N2 - Treatment guidelines for major depressive disorders suggest that combined treatment of pharmacotherapy and psychotherapy may be helpful in the acute phase of severe major depression.1 However, combined treatment is not strongly recommended in mild to moderate depression. In these cases, either pharmacotherapy or psychotherapy can be used, depending on the preference of the patient, the treatment history, and other clinical factors. However, is this recommendation still supported by the current state of knowledge? In this Viewpoint, I will discuss recent evidence suggesting that combined treatment could be a first-line treatment in the acute phase of mild to moderate depressive disorders and whether this evidence is strong enough to reconsider the recommendations in treatment guidelines.
AB - Treatment guidelines for major depressive disorders suggest that combined treatment of pharmacotherapy and psychotherapy may be helpful in the acute phase of severe major depression.1 However, combined treatment is not strongly recommended in mild to moderate depression. In these cases, either pharmacotherapy or psychotherapy can be used, depending on the preference of the patient, the treatment history, and other clinical factors. However, is this recommendation still supported by the current state of knowledge? In this Viewpoint, I will discuss recent evidence suggesting that combined treatment could be a first-line treatment in the acute phase of mild to moderate depressive disorders and whether this evidence is strong enough to reconsider the recommendations in treatment guidelines.
KW - Health sciences
KW - clinical pharmacy and Pharmacology
KW - Psychiatry
KW - Psychotherapy
KW - Depresssvice Disorders
KW - Psychology
UR - http://www.scopus.com/inward/record.url?scp=84903958524&partnerID=8YFLogxK
U2 - 10.1001/jamapsychiatry.2014.277
DO - 10.1001/jamapsychiatry.2014.277
M3 - Journal articles
C2 - 24806528
VL - 71
SP - 747
EP - 748
JO - JAMA - Journal of the American Medical Association
JF - JAMA - Journal of the American Medical Association
SN - 0098-7484
IS - 7
ER -